Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

NCT07182565 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Junction Adenocarcinoma
Hypofractionated Radiotherapy

Interventions

RADIATION: hypofractionated radiotherapy
DRUG: PD-1 inhibitor
DRUG: TS-1

Sponsor

West China Hospital